,mean_rank,weight
cervix,12.0,3.0
lung carcinoma,16.0,1.0
adrenal gland neuroblastoma,28.0,5.0
adrenal gland,30.0,3.0
small cell lung carcinoma,39.5,88.0
supra-orbital region,50.0,1.0
neuroblastoma,50.0,52.0
endometrioid stromal sarcoma,53.0,3.0
medulloblastoma,62.5,8.0
right pararenal lymph node,63.5,2.0
lung carcinoid tumor,66.0,6.0
pancreatic somatostatinoma,70.0,3.0
supraclavicular lymph node,75.0,3.0
gastric small cell neuroendocrine carcinoma,84.5,4.0
embryonal carcinoma,86.0,1.0
cervical small cell carcinoma,90.0,1.0
multiple endocrine neoplasia type 2,92.0,1.0
hereditary thyroid gland medullary carcinoma,92.0,1.0
"squamous cell breast carcinoma, acantholytic variant",95.0,3.0
alveolar rhabdomyosarcoma,96.0,9.0
brain,103.5,16.0
thyroid gland squamous cell carcinoma,106.0,3.0
right thigh skin,107.5,2.0
embryonal rhabdomyosarcoma,110.5,6.0
myeloid leukemia associated with down syndrome,112.0,1.0
uterine carcinosarcoma,112.5,2.0
prostate carcinoma,118.0,11.0
pharyngeal squamous cell carcinoma,123.0,3.0
abdomen,131.0,2.0
mediastinal lymph node,137.0,1.0
ovarian endometrioid adenocarcinoma,141.0,11.0
gastric adenosquamous carcinoma,149.5,2.0
salivary gland squamous cell carcinoma,151.0,3.0
large cell lung carcinoma,155.0,32.0
rhabdomyosarcoma,159.0,4.0
vertebra,166.0,2.0
ewing sarcoma,169.0,31.0
natural killer cell lymphoblastic leukemia/lymphoma,178.0,1.0
ovarian carcinoma,181.5,6.0
high grade ovarian serous adenocarcinoma,183.0,40.0
lung mucoepidermoid carcinoma,191.0,3.0
primary effusion lymphoma,193.0,3.0
endometrial adenosquamous carcinoma,193.0,6.0
brca1 syndrome,195.0,1.0
bone marrow,196.0,65.0
primitive neuroectodermal tumor,197.5,2.0
subserosa of fallopian tube,218.0,1.0
ovarian leiomyosarcoma,219.0,3.0
uterine corpus sarcoma,221.0,3.0
squamous cell lung carcinoma,223.5,48.0
adenosquamous lung carcinoma,224.0,9.0
oligodendroglioma,225.0,5.0
osteosarcoma,225.0,23.0
cervical squamous cell carcinoma,229.0,1.0
tonsillar squamous cell carcinoma,232.0,1.0
hypopharyngeal squamous cell carcinoma,232.0,5.0
testicular embryonal carcinoma,233.0,1.0
endometrial carcinoma,239.0,8.0
not specified,240.0,3.0
pyriform fossa squamous cell carcinoma,245.0,1.0
papillary renal cell carcinoma,245.0,5.0
undifferentiated gallbladder carcinoma,246.0,1.0
hodgkin lymphoma,249.0,11.0
thoracic lymph duct,250.0,1.0
ovarian adenocarcinoma,251.0,5.0
floor of mouth squamous cell carcinoma,256.0,1.0
ovarian serous adenocarcinoma,258.0,7.0
malignant ovarian brenner tumor,262.0,1.0
askin tumor,263.5,2.0
peritoneal ascites,264.5,2.0
spleen,265.0,3.0
minimally invasive lung adenocarcinoma,266.0,16.0
plasma cell myeloma,278.5,30.0
right anterior leg,282.0,3.0
brca2 syndrome,292.0,1.0
ovarian granulosa cell tumor,299.0,2.0
neurofibromatosis type 1,302.0,1.0
thyroid gland follicular carcinoma,303.0,10.0
human papillomavirus-related endocervical adenocarcinoma,309.5,4.0
lung adenocarcinoma,315.0,145.0
cystic fibrosis,315.5,2.0
brachialis muscle,316.0,3.0
lymph node,320.0,105.0
breast carcinoma,320.0,27.0
hepatoblastoma,321.0,4.0
ascites,323.0,103.0
duodenal adenocarcinoma,327.0,1.0
esophageal squamous cell carcinoma,327.0,59.0
gallbladder carcinoma,328.5,2.0
hairy cell leukemia,329.0,3.0
poorly differentiated thyroid gland carcinoma,330.0,3.0
squamous papilloma,330.0,1.0
pleural effusion,333.0,224.0
intrahepatic cholangiocarcinoma,335.5,6.0
benign prostatic hyperplasia,340.0,1.0
endometrial adenocarcinoma,347.5,34.0
rhabdoid tumor of the kidney,350.0,3.0
oral dysplasia,352.0,1.0
glioblastoma,353.5,84.0
abdominal wall,356.5,2.0
ductal breast carcinoma,357.0,32.0
bladder carcinoma,359.0,51.0
barrett adenocarcinoma,360.0,3.0
axillary lymph node,360.5,6.0
ovarian serous cystadenocarcinoma,362.0,4.0
epstein-barr virus-related burkitt lymphoma,363.0,10.0
cutaneous melanoma,365.0,26.0
tongue squamous cell carcinoma,366.5,34.0
vulvar leiomyosarcoma,367.0,3.0
cerebrospinal fluid,370.0,3.0
oral cavity squamous cell carcinoma,371.5,6.0
gastric carcinoma,371.5,12.0
laryngeal squamous cell carcinoma,380.0,12.0
n/a,382.5,34.0
liver,384.0,32.0
bladder squamous cell carcinoma,386.0,3.0
ovarian clear cell adenocarcinoma,387.0,13.0
skin,388.0,3.0
ovarian mixed germ cell tumor,391.0,1.0
pancreatic ductal adenocarcinoma,391.0,39.0
signet ring cell gastric adenocarcinoma,392.0,9.0
lung giant cell carcinoma,392.0,4.0
thyroid gland undifferentiated (anaplastic) carcinoma,395.0,13.0
gingival squamous cell carcinoma,395.5,2.0
gastric adenocarcinoma,396.5,26.0
mediastinal (thymic) large b-cell lymphoma,398.0,1.0
omentum,399.0,7.0
ovarian cystadenocarcinoma,401.5,6.0
"invasive ductal carcinoma, not otherwise specified",403.0,30.0
hepatocellular carcinoma,404.0,51.0
pleural epithelioid mesothelioma,404.0,18.0
gliosarcoma,406.5,6.0
inguinal lymph node,408.0,3.0
pancreatic carcinoma,409.5,12.0
anaplastic large cell lymphoma,410.5,8.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",411.0,2.0
cervical carcinoma,413.5,2.0
bronchogenic carcinoma,414.5,2.0
mucinous gastric adenocarcinoma,415.0,3.0
intraperitoneal,415.0,1.0
diffuse large b-cell lymphoma germinal center b-cell type,415.0,8.0
pancreatic adenocarcinoma,416.0,39.0
gastric fundus carcinoma,416.0,1.0
breast adenocarcinoma,418.0,23.0
small intestine,419.0,1.0
skin nodule,423.0,1.0
melanoma,426.5,94.0
ovarian mucinous cystadenocarcinoma,426.5,2.0
groin lymph node,427.0,5.0
marek disease,428.0,1.0
b acute lymphoblastic leukemia,429.0,5.0
cervical lymph node,430.0,5.0
acute myeloid leukemia,434.0,1.0
mandible,436.0,1.0
renal cell carcinoma,439.0,37.0
amelanotic melanoma,443.5,16.0
fibrosarcoma,444.0,5.0
celiac axis lymph node,446.5,2.0
rectal adenocarcinoma,447.0,11.0
pleural sarcomatoid mesothelioma,447.5,8.0
clear cell renal cell carcinoma,447.5,18.0
subcutaneous,452.0,7.0
diffuse large b-cell lymphoma,453.0,20.0
human papillomavirus-related cervical squamous cell carcinoma,456.0,8.0
lung,457.0,7.0
cutaneous t-cell non-hodgkin lymphoma,461.5,2.0
burkitt lymphoma,466.0,8.0
familial adenomatous polyposis,467.0,1.0
vulvar squamous cell carcinoma,468.0,3.0
pericardial effusion,468.5,8.0
childhood acute myeloid leukemia with maturation,470.0,1.0
ovarian mucinous adenocarcinoma,470.0,4.0
pleural biphasic mesothelioma,471.0,7.0
myelodysplastic syndrome,472.0,1.0
down syndrome,474.0,2.0
gastric tubular adenocarcinoma,475.0,11.0
non-small cell lung carcinoma,476.0,24.0
invasive lobular breast carcinoma,478.0,1.0
pancreatic adenosquamous carcinoma,484.0,5.0
gastric choriocarcinoma,484.0,1.0
astrocytoma,486.0,19.0
"chronic eosinophilic leukemia, not otherwise specified",491.0,1.0
cecum adenocarcinoma,494.0,18.0
recurrent bladder carcinoma,495.0,3.0
ampulla of vater adenocarcinoma,495.0,2.0
colon carcinoma,500.0,19.0
skin squamous cell carcinoma,507.0,1.0
left supraclavicular lymph node,507.5,4.0
pelvic wall,510.0,3.0
erythroleukemia,511.0,3.0
left leg muscle,514.0,3.0
bone,514.0,1.0
esophageal adenocarcinoma,515.0,9.0
obturator lymph node,519.0,3.0
rectosigmoid adenocarcinoma,520.0,3.0
mantle cell lymphoma,521.0,6.0
chronic lymphocytic leukemia,522.0,2.0
peripheral blood,529.0,107.0
peritoneal effusion,530.0,6.0
childhood t lymphoblastic lymphoma,530.5,2.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",535.5,2.0
paragastric lymph node,539.5,2.0
thyroid gland sarcoma,543.0,1.0
hilar cholangiocarcinoma,544.0,1.0
pleural malignant mesothelioma,545.0,5.0
b-cell prolymphocytic leukemia,549.5,2.0
mycosis fungoides and sezary syndrome,557.5,2.0
head and neck squamous cell carcinoma,558.0,9.0
"chronic myelogenous leukemia, bcr-abl1 positive",559.0,16.0
epithelioid cell type gastrointestinal stromal tumor,561.0,3.0
biphasic synovial sarcoma,563.0,1.0
liposarcoma,568.0,1.0
undifferentiated pleomorphic sarcoma,580.5,4.0
colon adenocarcinoma,582.0,61.0
adult b acute lymphoblastic leukemia,591.0,3.0
buccal mucosa squamous cell carcinoma,592.0,2.0
thigh skin,598.0,1.0
lymphoma,600.0,1.0
buttock,602.0,2.0
b-cell non-hodgkin lymphoma,618.0,7.0
subcutaneous; right buttock,629.0,3.0
papillary lung adenocarcinoma,630.0,3.0
vaginal melanoma,634.0,1.0
anaplastic astrocytoma,635.0,5.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),640.5,4.0
chondrosarcoma,643.0,10.0
right axillary lymph node,643.0,1.0
childhood t acute lymphoblastic leukemia,648.0,19.0
adult acute monocytic leukemia,660.0,5.0
pelvis; innominate bone,665.5,2.0
childhood acute myeloid leukemia,669.0,2.0
hereditary spherocytosis,675.0,1.0
diffuse large b-cell lymphoma activated b-cell type,679.0,1.0
follicular lymphoma,686.5,2.0
adult acute myeloid leukemia,686.5,22.0
uterine corpus leiomyosarcoma,692.0,3.0
adrenal cortex carcinoma,701.0,1.0
splenic lymphoma with circulating villous lymphocytes,715.0,1.0
parotid gland mucoepidermoid carcinoma,733.0,1.0
cholangiocarcinoma,748.5,2.0
gestational choriocarcinoma,763.0,2.0
peritoneum,802.0,1.0
lymphoblastic lymphoma,804.0,1.0
squamous cell carcinoma,806.0,1.0
vulvar carcinoma,847.0,1.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,852.0,1.0
childhood b acute lymphoblastic leukemia,862.0,9.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,862.0,3.0
acute myelomonocytic leukemia,873.0,1.0
meninges,873.0,1.0
childhood acute monocytic leukemia,873.5,2.0
adult t acute lymphoblastic leukemia,905.0,5.0
ovary,962.0,1.0
thyroid gland papillary carcinoma,965.0,1.0
left cervical lymph node,965.0,1.0
vulvar melanoma,969.0,1.0
epithelioid sarcoma,981.0,1.0
